Annual Shareholders Equity
$405.33 M
+$207.94 M+105.35%
31 December 2023
Summary:
Madrigal Pharmaceuticals annual stockholders equity is currently $405.33 million, with the most recent change of +$207.94 million (+105.35%) on 31 December 2023. During the last 3 years, it has risen by +$165.36 million (+68.91%). MDGL annual shareholders equity is now -15.02% below its all-time high of $476.98 million, reached on 31 December 2018.MDGL Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$777.15 M
-$79.97 M-9.33%
30 September 2024
Summary:
Madrigal Pharmaceuticals quarterly stockholders equity is currently $777.15 million, with the most recent change of -$79.97 million (-9.33%) on 30 September 2024. Over the past year, it has increased by +$754.91 million (+3392.99%). MDGL quarterly shareholders equity is now -9.33% below its all-time high of $857.12 million, reached on 30 June 2024.MDGL Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MDGL Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +105.3% | +3393.0% |
| 3 y3 years | +68.9% | +230.9% |
| 5 y5 years | -15.0% | +76.5% |
MDGL Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +106.7% | -9.3% | +7183.6% |
| 5 y | 5 years | -15.0% | +106.7% | -9.3% | +7183.6% |
| alltime | all time | -15.0% | +789.5% | -9.3% | +977.4% |
Madrigal Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $777.15 M(-9.3%) |
| June 2024 | - | $857.12 M(+0.7%) |
| Mar 2024 | - | $850.76 M(+109.9%) |
| Dec 2023 | $405.33 M(+105.3%) | $405.33 M(+1721.8%) |
| Sept 2023 | - | $22.25 M(-78.5%) |
| June 2023 | - | $103.51 M(-31.1%) |
| Mar 2023 | - | $150.14 M(-23.9%) |
| Dec 2022 | $197.39 M(+0.7%) | $197.39 M(+1749.9%) |
| Sept 2022 | - | $10.67 M(-87.2%) |
| June 2022 | - | $83.53 M(-42.7%) |
| Mar 2022 | - | $145.74 M(-25.7%) |
| Dec 2021 | $196.11 M(-18.3%) | $196.11 M(-16.5%) |
| Sept 2021 | - | $234.88 M(-13.2%) |
| June 2021 | - | $270.65 M(+3.9%) |
| Mar 2021 | - | $260.55 M(+8.6%) |
| Dec 2020 | $239.97 M(-42.4%) | $239.97 M(-17.2%) |
| Sept 2020 | - | $289.70 M(-15.5%) |
| June 2020 | - | $342.92 M(-11.0%) |
| Mar 2020 | - | $385.48 M(-7.5%) |
| Dec 2019 | $416.56 M(-12.7%) | $416.56 M(-5.4%) |
| Sept 2019 | - | $440.35 M(-3.6%) |
| June 2019 | - | $456.99 M(-2.5%) |
| Mar 2019 | - | $468.51 M(-1.8%) |
| Dec 2018 | $476.98 M(+161.7%) | $476.98 M(-1.2%) |
| Sept 2018 | - | $482.91 M(-0.7%) |
| June 2018 | - | $486.09 M(+174.3%) |
| Mar 2018 | - | $177.18 M(-2.8%) |
| Dec 2017 | $182.26 M(+400.6%) | $182.26 M(+235.6%) |
| Sept 2017 | - | $54.31 M(-11.9%) |
| June 2017 | - | $61.63 M(+78.9%) |
| Mar 2017 | - | $34.45 M(-5.4%) |
| Dec 2016 | $36.41 M(-174.4%) | $36.41 M(-3.1%) |
| Sept 2016 | - | $37.59 M(-9.6%) |
| June 2016 | - | $41.57 M(-6.2%) |
| Mar 2016 | - | $44.33 M(-190.6%) |
| Dec 2015 | -$48.91 M(-175.1%) | -$48.91 M(-181.0%) |
| Sept 2015 | - | $60.37 M(-12.5%) |
| June 2015 | - | $68.98 M(+49.5%) |
| Mar 2015 | - | $46.14 M(-29.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $65.14 M(+32.7%) | $65.14 M(-22.2%) |
| Sept 2014 | - | $83.73 M(+13.1%) |
| June 2014 | - | $74.00 M(+93.6%) |
| Mar 2014 | - | $38.22 M(-22.1%) |
| Dec 2013 | $49.09 M(-34.6%) | $49.09 M(+236.0%) |
| Sept 2013 | - | $14.61 M(-58.8%) |
| June 2013 | - | $35.44 M(-37.4%) |
| Mar 2013 | - | $56.60 M(-24.6%) |
| Dec 2012 | $75.07 M(+408.1%) | $75.07 M(+133.2%) |
| Sept 2012 | - | $32.19 M(+57.3%) |
| June 2012 | - | $20.46 M(-39.4%) |
| Mar 2012 | - | $33.77 M(+128.6%) |
| Dec 2011 | $14.77 M(-37.1%) | $14.77 M(-39.9%) |
| Sept 2011 | - | $24.58 M(-32.5%) |
| June 2011 | - | $36.44 M(+178.1%) |
| Mar 2011 | - | $13.10 M(-44.2%) |
| Dec 2010 | $23.48 M(-5.7%) | $23.48 M(-10.6%) |
| Sept 2010 | - | $26.26 M(-26.1%) |
| June 2010 | - | $35.52 M(-18.1%) |
| Mar 2010 | - | $43.39 M(+74.2%) |
| Dec 2009 | $24.91 M(-142.4%) | $24.91 M(-19.2%) |
| Sept 2009 | - | $30.84 M(-134.8%) |
| June 2009 | - | -$88.57 M(+9.2%) |
| Mar 2009 | - | -$81.13 M(+38.0%) |
| Dec 2008 | -$58.79 M(-336.1%) | -$58.79 M(+69.9%) |
| Sept 2008 | - | -$34.61 M(+238.9%) |
| June 2008 | - | -$10.21 M(-195.2%) |
| Mar 2008 | - | $10.72 M(-56.9%) |
| Dec 2007 | $24.90 M(-1525.1%) | $24.90 M(-36.3%) |
| Sept 2007 | - | $39.07 M(-25.5%) |
| June 2007 | - | $52.46 M(-24.6%) |
| Mar 2007 | - | $69.54 M(-4080.4%) |
| Dec 2006 | -$1.75 M(-103.3%) | -$1.75 M(-116.9%) |
| Sept 2006 | - | $10.35 M(-80.3%) |
| Dec 2005 | $52.48 M(-55.5%) | $52.48 M(-48.1%) |
| Mar 2005 | - | $101.07 M |
| Dec 2004 | $117.96 M(+53.4%) | - |
| Dec 2003 | $76.89 M(+2702.2%) | - |
| Dec 2001 | $2.74 M | - |
FAQ
- What is Madrigal Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual shareholders equity year-on-year change?
- What is Madrigal Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Madrigal Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of MDGL is $405.33 M
What is the all time high annual shareholders equity for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual stockholders equity is $476.98 M
What is Madrigal Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, MDGL annual stockholders equity has changed by +$207.94 M (+105.35%)
What is Madrigal Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of MDGL is $777.15 M
What is the all time high quarterly shareholders equity for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly stockholders equity is $857.12 M
What is Madrigal Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, MDGL quarterly stockholders equity has changed by +$754.91 M (+3392.99%)